Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration

被引：0
|
作者：
Bergemann, N [1 ]
Frick, A [1 ]
Kress, KR [1 ]
Kopitz, J [1 ]
机构：
[1] Univ Heidelberg, Dept Psychiat, D-6900 Heidelberg, Germany
来源：
PHARMACOPSYCHIATRY | 2003年 / 36卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
23
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [21] OPTIMISING CLOZAPINE THERAPY: A NEW MODEL OF CLOZAPINE THERAPEUTIC DRUG MONITORING
    Ray, John
    Campbell, Gillian
    Richardson, Tony
    Erickson, Gill
    Carr, Vaughan
    Rofe, Peter
    Tassaneeyakul, Wichittra
    Graham, Gary
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 : A26 - A26
  • [22] A 5-year retrospective study of amisulpride steady-state plasma concentration in patients with schizophrenia in real-life settings based on therapeutic drug monitoring data
    Ding, Jing
    Yang, Liu
    Cui, Xiaohua
    Li, Luyao
    Liu, Jiarui
    Sun, Hongrui
    Wang, Ting
    Zhang, Yan
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 87
  • [23] Amisulpride has no effect on plasma clozapine concentrations
    Bergemann, N
    Kress, KR
    Frick, A
    Kopitz, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 494 - 497
  • [24] A retrospective study of clozapine and norclozapine concentration in patients with schizophrenia: Data from the Therapeutic Drug Monitoring Service, 2019-2022
    Ding, Jing
    Liu, Jianfeng
    Zhang, Yan
    Xing, Huan
    Zhang, Yang
    Li, Luyao
    Zhang, Suo
    Wang, Huiyuan
    Yang, Liu
    Cui, Xiaohua
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 91
  • [25] Olanzapine and risperidone plasma concentration therapeutic drug monitoring: A feasibility study
    Law, Suzanne
    Gudbrandsen, Maria
    Magill, Nicholas
    Sweetman, Isabel
    Rose, Diana
    Landau, Sabine
    Flanagan, Robert J.
    David, Anthony S.
    Patel, Maxine X.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (08) : 933 - 942
  • [26] The significance of sampling time in therapeutic drug monitoring of clozapine
    Jakobsen, M. I.
    Larsen, J. R.
    Svensson, C. K.
    Johansen, S. S.
    Linnet, K.
    Nielsen, J.
    Fink-Jensen, A.
    ACTA PSYCHIATRICA SCANDINAVICA, 2017, 135 (02) : 159 - 169
  • [27] NOVEL TECHNIQUES FOR THERAPEUTIC DRUG MONITORING FOR CLOZAPINE LEVELS
    Vyas, Gopal
    Buckley, Tiffany
    Kitchen, Christopher
    Siegfried, Nathan
    Tefera, Eshetu
    Chen, Shou
    DiPaula, Bethany
    Kelly, Deanna
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S350 - S351
  • [28] THERAPEUTIC DRUG MONITORING WITH CLOZAPINE: ELECTROCHEMICAL SENSING DEVELOPMENT
    Kang, Mijeong
    Kitchen, Christopher
    Kelly, Deanna
    Kim, Eunkyoung
    Winkler, Thomas
    Banis, George
    Liu, Yi
    Ghodssi, Reza
    Payne, Gregory
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S253 - S253
  • [29] Therapeutic Drug Monitoring of Clozapine TreatmentTherapeutic Threshold Value for Serum Clozapine Concentrations
    Ole Vendelin Olesen
    Clinical Pharmacokinetics, 1998, 34 : 497 - 502
  • [30] Plasma Clozapine, Norclozapine, and the Clozapine: Norclozapine Ratio in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 1993-2007
    Couchman, Lewis
    Morgan, Phillip Edgar
    Spencer, Edgar Pathrose
    Flanagan, Robert James
    THERAPEUTIC DRUG MONITORING, 2010, 32 (04) : 438 - 447
12345